Publication of Mineral Resource Estimate for Storeknuten in the Høyland Exploration Area
4.5.2021 09:55:00 EEST | Business Wire | Press release
Norge Mining plc, the Anglo-Norwegian mineral exploration company focused on the Bjerkreim Exploration Project in southwest Norway, announces publication of a Mineral Resource Estimate for the Storeknuten Deposit in the Høyland Exploration Area. The data confirms Storeknuten as the Company’s second world-class discovery in the Bjerkreim Exploration Project.
The Storeknuten Mineral Resource covers an area of about 400,000 sq m, which represents approximately 15% of the Høyland Exploration Area.
Publication of the Storeknuten Mineral Resource Estimate follows publication in February this year of the maiden Mineral Resource Estimate at Øygrei, a world-class deposit of 1.55 billion tonnes which is currently being extended and upgraded.
Highlights
- Maiden Mineral Resource Estimate reported for Storeknuten of 240 million tonnes, containing mean grades of 2.36% phosphorus pentoxide, 4.71% titanium dioxide and 0.07% vanadium pentoxide.
- Storeknuten is the Company’s second world-class resource of EU Critical Raw Materials, defined as materials of strategic importance for the European economy that the EU currently imports.
- The Mineral Resource Estimate at Storeknuten was prepared according to the JORC2 reporting standard by SRK Exploration Services Ltd (SRK), part of the SRK Group, which is an independent international mining, exploration and environmental consultant.
- The Storeknuten Mineral Resource Estimate is summarised below:
|
Mineral Resource Classification |
Tonnes
|
P2O5 Grade
|
TiO2 Grade
|
V2O5 Grade
|
|
Inferred |
240.0 |
2.36 |
4.71 |
0.07 |
|
Total |
240.0 |
2.36 |
4.71 |
0.07 |
- The higher phosphate grade of this deposit opens up potential opportunities for alternative mining and processing scenarios.
- Exploration work at Storeknuten is ongoing firstly to extend the resource and then in due course to improve confidence in the estimate with the aim of upgrading a portion of the resource to the Indicated category.
John Vergopoulos, Chief Executive Officer of Norge Mining, said:
“This Mineral Resource Estimate confirms Storeknuten as our second world-class deposit, further highlighting the potential of the Bjerkreim Exploration Project as a whole. In addition to 240 million tonnes of Inferred Mineral Resource at Storeknuten, SRK has also reported a very substantial Exploration Target of between 1.4 and 2.0 billion tonnes."
“Given the constraints of Covid-19 on exploration work at Storeknuten during the past year, I am particularly pleased by this initial Mineral Resource Estimate."
“Together with Øygrei, whose world-class status was established earlier this year, we now have a total Mineral Resource Estimate at Bjerkreim of 1.79 billion tonnes and an Exploration Target of between 2.4 and 4.0 billion tonnes, all containing vanadium, titanium and phosphate."
“These three minerals are on the EU’s list of Critical Raw Materials, giving Norway a major opportunity to play a pivotal strategic role in the future supply of these materials."
“Exploration work is ongoing to upgrade and extend the resource at both Storeknuten and Øygrei. We also continue to drill in other areas and expect to announce further data in the coming months.”
An executive summary of the Storeknuten Mineral Resource Estimate is available at the Company’s website: www.norgemining.com
Background to the Bjerkreim Exploration Project
The Bjerkreim Exploration Project is located in southwest Norway in the large Bjerkreim-Sokndal Layered Intrusion, which has been widely studied by the Norway Geological Survey (NGU) and other researchers. Norge Mining is focusing on the Bjerkreim Lobe of this intrusion, which forms a large synclinal trough structure. This trough extends at outcrop for some 20km northwest-southeast and up to 10km northeast-southwest. It is known to extend for several kilometres in depth.
The mineralisation consists of primary magmatic mineral assemblages in which vanadium-bearing magnetite, ilmenite (titanium) and apatite (phosphate) represent the minerals of interest. Vanadium, titanium and phosphate are all on the EU’s list of Critical Raw Materials, defined as materials of strategic importance for the European economy that the EU currently imports.
Through its Norwegian subsidiary Norge Mineraler AS, Norge Mining has 46 exploration licences in southwest Norway, totalling more than 400 sq km. The Company has conducted extensive ongoing exploration work at Bjerkreim, including channel sampling, aerial surveys and shallow and deep drilling. In total, more than 30,000m of drilling has now been completed.
Storeknuten forms part of the Høyland Exploration Area in the Bjerkreim Exploration Project. It covers an area of 1,150m by 350m and is located 4.5km southwest from the Company’s Øygrei Deposit.
SRK Exploration Services Ltd (SRK), part of the SRK Group, an international mining, exploration and environmental consultant, has prepared the Mineral Resource Estimate at Storeknuten. The diamond drilling programme at Storeknuten began in September 2020 and the data cut-off used to produce the resource estimate was 1 March 2021. The data for resource estimation was derived from 1,437 assayed samples from 9 drill holes.
Storeknuten Mineral Resource Estimate
SRK’s maiden Mineral Resource Estimate for the Storeknuten area of the Bjerkreim Exploration Project, reported according to the JORC Code reporting standard, is summarised below:
|
Mineral Resource Classification |
Tonnes
|
P2O5 Grade
|
TiO2 Grade
|
V2O5 Grade
|
|
Inferred |
240.0 |
2.36 |
4.71 |
0.07 |
|
Total |
240.0 |
2.36 |
4.71 |
0.07 |
As is the case at Øygrei, the mineralisation occurs in steep dipping layers that are continuous down dip and along strike. The vast majority of the reported Mineral Resource correlates to the B Zone previously reported on at Øygrei and, while it does contain a small amount of C Zone, it does not contain any New Zone and consequently the P2O5 grades are higher.
In reporting a Mineral Resource, there is a requirement that there are reasonable prospects for eventual economic extraction. In this case, the requirement has been achieved by limiting the tonnage reported to that falling within an open pit which was optimised assuming selling prices of USD230/t of ilmenite, USD97.75/t of phosphate and USD9.2/lb of V2O5.
Storeknuten Exploration Target
SRK has delineated a Storeknuten Exploration Target, also as defined by the JORC Code, of between 1.4 and 2.0 billion tonnes of mineralisation with similar grades to that already reported (between 1.6 and 2.4% P2O5, 4.2 and 5.0% TiO2 and 0.06 and 0.08% V2O5).
This Exploration Target is based on the assumed continuity of the mineralised layers at Storeknuten at depth and to the northeast. Surface geology supports this continuity, and the mineralisation drilled to date remains open in these directions. It should however be noted that the Exploration Target potential tonnage and grade estimates are conceptual in nature, that there has been insufficient exploration to estimate a Mineral Resource and that it is uncertain if further exploration will result in the estimation of a Mineral Resource.
Next Steps
Exploration work at Storeknuten is ongoing with a substantial, planned programme of additional drilling to upgrade and extend the Mineral Resource and to provide information for a scoping study. The drilling work is expected to be completed this year.
Exploration work at Øygrei, and elsewhere in the Bjerkreim Exploration Project including Skeipstad, is also ongoing. At Øygrei more than 13,000m of infill and geotechnical drilling is underway, part of the aim of which is to increase confidence in the Mineral Resource and enable more to be reported in the Indicated category.
1 World-class deposit is used in the context of this announcement to mean a deposit of very large size with the potential to provide major economic and strategic benefits.
2 The reporting standard for this statement is the 2012 edition of the “Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves” as published by the Joint Ore Reserves Committee of the Australasian Institute of Mining and Metallurgy, Australian Institute of Geoscientists and Minerals Council of Australia” (the “JORC Code”). The JORC Code is a reporting code which has been aligned with the Committee for Mineral Reserves International Reporting Standards (“CRIRSCO”) reporting template and is an internationally recognised reporting standard that has been adopted worldwide for market-related reporting and financial investments.
The Competent Person who has overall responsibility for the Mineral Resource is Dr Mike Armitage, C.Eng, C. Geol, FGS, MIMM, PhD. Dr Armitage is a Chartered Geologist which is a Recognised Professional Organisation (“RPO”) included in a list promulgated by the Australian Securities Exchange (“ASX”) from time to time. He is a full time employee of SRK Consulting (UK) Ltd and a director of SRK Exploration Services, a corporate consultant and has over 35 years’ experience in the mining and metals industry and also has sufficient experience which is relevant to the style of mineralisation and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the JORC Code. Dr Armitage has been responsible for the reporting of Mineral Resources and Ore Reserves on various properties internationally during the past 30 years.
About Norge Mining plc
Norge Mining plc is an Anglo-Norwegian natural resources company focused on mineral exploration in Norway.
The Company owns 46 exploration licences, totalling more than 400 square kilometres in south-west Norway in an area known to contain vanadium, titanium, phosphate and gold. Norge Mining is currently conducting a programme of exploration work to produce a resource estimate, building on earlier studies by the Norway Geological Survey (NGU).
Norge Mining’s ambition is to become a substantial, sustainable and strategically important exploration and mining business focused on Norway.
The Company was founded in November 2018, is headquartered in the UK and has a 100%-owned Norwegian subsidiary, Norge Mineraler AS.
For further information, please visit www.norgemining.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005833/en/
Contact information
Buchanan Communications
Mark Court / James Husband
+44 (0) 20 7466 5000
norgemining@buchanan.uk.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 11:15:00 EEST | Press release
Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easier to access, navigate and manage. This will ultimately give pet parents better guidance, greater confidence and more control at every point in
Coolbrook Secures Business Finland Funding to Accelerate Electrification for the Global Steel Industry29.6.2026 11:00:00 EEST | Press release
Coolbrook, a transformational technology company dedicated to decarbonising heavy industry and industrial processes, has been awarded research and development funding by Business Finland to accelerate the decarbonisation of steel production. The grant supports Coolbrook’s participation in the FutSteel project, a core component of the Sustainable World through Steels ecosystem led by SSAB. Within the broader FutSteel project, Coolbrook’s project scope amounts to €5 million, of which €2.5 million is covered by grant funding awarded to Coolbrook. The funding will enable Coolbrook to further accelerate and develop its next-generation RotoDynamic Heater™ (RDH™) technology, specifically tailored for high-temperature steel industry applications. The project focuses on integrating RDH™ technology into critical stages of the steel production chain, including blast furnace processes, electrified reheating, hot-stove air pre-heating, hybrid-heating concepts, decarbonised Direct Reduced Iron (DRI)
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 10:19:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patients with unmet needs.” Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to treat vari
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 10:00:00 EEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 10:00:00 EEST | Press release
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on data from the Phase 3 RISE-PD trial, which compared Hopledo® with immediate release levodopa/carbidopa (LD/CD) formulation in patients with Parkinson’s disease and moderate to severe motor fluctuations. In the study, Hopledo® demonstrated a significant increase in Good ON time over immediate release LD/CD with fewer daily doses and a comparable safety profile1. Hopledo® is a first-in-class, oral, modified-release formulation of LD/CD designed for the treatment of fluctuations of Parkinson’s diseas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
